Sectors
Games developer Realtime Worlds enters restructuring after more than $80m of venture funding.
Listing of biotechnology group Pacific Biosciences comes a month after bumper series F round.
OriGene Technologies has acquired Blue Heron Biotechnology from its venture investment backers, including Nasdaq-listed Invitrogen.
Siemens and DTE Energy's venture divisions had backed clean-tech ISE through to its flotation but company struggled with weak economy.
IDG-Accel-backed Kanghui prices in middle of its initial public offering range in New York.
Tektronix Communications has agreed to acquire venture-backed Arbor Networks for an undisclosed sum.
BlueRun-backed Slide sells for reportedly up to $228m to search engine group Google.
Safeguard Scientifics and SR One-baved drugs company NuPathe amends listing price to $10 per share.
Merck and Siemens sell out of VisEn Medical in exit to New York-listed medical technology company PerkinElmer.
Intel Capital-backed Trony Solar, a China-based manufacturer of solar power parts, has withdrawn its planned US flotation plans from the regulator.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
